Eli Lilly and Company
Discovery Automation Group Leader
Ryan Bernhardt has spent the past five years at Eli Lilly and Company in Indianapolis, IN as part of the Discovery Automation Research and Technologies Group; leading a team of automation engineers and scientists in the design, implementation, and operation of a variety of innovative automation projects across Lilly’s Research and Development Laboratories. During his time at Lilly, Ryan has also contributed as the Automation Architect and Integration Leader for the Lilly Life Sciences Studio (L2S2); a state-of-the-art, fully automated Drug Discovery Platform located at Lilly’s Biotechnology Center in La Jolla, CA. Ryan received Lilly’s Top 100 Innovator Award for his track-based, modular design of L2S2 which incorporates a multi-level scheduling software infrastructure. This physical and digital automation architecture has influenced the design of many other automated platforms at Lilly and across the external Life Science community.
This webinar, presented by Ryan Bernhardt, describes the Lilly Life Sciences Studio Lab (L2S2), a robotic laboratory designed to accelerate the drug discovery process. The vision of the studio is to streamline the design, make, test, and analyze steps of the drug discovery cycle through an open platform accessible to researchers throughout the life science industry.